Morphic Holding Inc 's ROA from the second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Morphic Holding Inc 's ROA in the second quarter of 2024?
Morphic Holding Inc recorded a cumulative net loss of $-180 million during 12 months ending in the second quarter of 2024, resulting in a negative return on assets (ROA) of -25.74%.

However, within the Healthcare sector 418 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2024 from 3823 to 3835.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Total Assets Change	-13.71 %	54.49 %	96.17 %	91.01 %	80.9 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-180	-161	-152	-136	-130
Return On Assets (TTM)	-25.74 %	-22.26 %	-22.9 %	-23.58 %	-26.6 %
MORF's Total Ranking	# 3835	# 3823	# 4408	# 3954	# 4091
Total Assets (TTM) in million	646	683	723	743	749
Seq. Total Assets Change	-5.37 %	-5.5 %	-2.81 %	-0.71 %	69.41 %
Seq. Net Income Change	-	-	-	-	-

MORF's 5 Years Annual ROA >> Back to MORF Management Effectiveness >> Compare MORF ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 156
Sector	# 419
Overall	# 3772

Return On Assets Statistics
High	Average	Low
44.08 %	-11.02 %	-26.59 %
(Dec 31 2019)		(Jun 30 2023)

Financial Statements
Morphic Holding Inc 's Assets	$ 646 million	MORF's Balance sheet
Morphic Holding Inc 's Income	$ -58 million	Quarterly MORF's Income Statement
MORF's Income by Division		See MORF's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2018) FY 2019
Y / Y Total Assets Change	96.17 %	-13.6 %	73.25 %	29.22 %	-
Total Assets in million	723	368	426	246	190
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-152	-59	-96	-45	-24
Annual Return On Assets	-21.05 %	-16.03 %	-22.41 %	-18.29 %	-12.52 %

MORF's 5 Years Annual ROA >> Back to MORF Management Effectiveness >> Compare MORF ROA to its Competitors

More Return On Assets Ratios
MORF's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MORF's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MORF's Competitors
Subscribers only: Roa for Morphic Holding Inc 's Suppliers
Subscribers only: Return On Assets for MORF's Customers

You may also want to know
MORF's Roi	MORF's Inventory Turnover Ratio	MORF's Growth Rates	MORF's Dividend Comparisons
	MORF's Profitability Ratios	MORF's Asset Turnover Ratio	MORF's Dividend Growth
MORF's Roe	MORF's Valuation Ratios	MORF's Financial Strength Ratios	MORF's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2024, within Healthcare Sector

ROA

Date modified: 2026-09-08T19:02:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.